{"date":"2025-11-21","count":19,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7850-2025-11-21-2048-7rzr08","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"20:48:47","subject":"公告本公司法人董事指派代表人","clause":"第6款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-11-21 20:48，「公告本公司法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-11-21-2048-1asybg7","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"20:48:26","subject":"公告本公司成立第一屆審計委員會及委任第二屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-11-21 20:48，「公告本公司成立第一屆審計委員會及委任第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-11-21-2048-1m17pam","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"20:48:01","subject":"公告本公司董事會選任董事長及副董事長","clause":"第6款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-11-21 20:48，「公告本公司董事會選任董事長及副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-11-21-2047-f87r5g","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"20:47:41","subject":"公告本公司114年第二次股東臨時會通過解除新任董事競業禁止之限制","clause":"第22款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-11-21 20:47，「公告本公司114年第二次股東臨時會通過解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-11-21-2047-ayydu0","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"20:47:14","subject":"公告本公司114年第二次股東臨時會全面改選董事(含獨立董事)暨三分之一以上董事之變動","clause":"第6款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-11-21 20:47，「公告本公司114年第二次股東臨時會全面改選董事(含獨立董事)暨三分之一以上董事之變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-11-21-2046-1ye5yun","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"20:46:34","subject":"公告本公司114年第二次股東臨時會重要決議事項","clause":"第15款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-11-21 20:46，「公告本公司114年第二次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-11-21-1821-lxl9m","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-21","time":"18:21:29","subject":"本公司子公司合富(香港)控股股份有限公司擬處份重要子公司合富(中國)醫療科技股份有限公司股權案","clause":"第20款","fact_date":"2030-11-21","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-11-21 18:21，「本公司子公司合富(香港)控股股份有限公司擬處份重要子公司合富(中國)醫療科技股份有限公司股權案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-11-21-1821-1qytcve","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-21","time":"18:21:07","subject":"公告本公司董事會通過對關係人捐贈事宜","clause":"第43款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-11-21 18:21，「公告本公司董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2025-11-21-1803-wijn5f","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2025-11-21","time":"18:03:11","subject":"公告本公司召開114年第二次法人說明會","clause":"第12款","fact_date":"2025-11-28","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2025-11-21 18:03，「公告本公司召開114年第二次法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-11-21-1756-p67uuk","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"17:56:20","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-11-21 17:56，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-11-21-1745-2e7e5w","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-21","time":"17:45:43","subject":"代子公司共信醫藥科技股份有限公司公告向日本特許廳提出之專利申請案號：特願2024-519389 已獲核准通知","clause":"第53款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-11-21 17:45，「代子公司共信醫藥科技股份有限公司公告向日本特許廳提出之專利申請案號：特願2024-519389 已獲核准通知」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2025-11-21-1740-d918s4","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"17:40:46","subject":"本公司受邀參加兆豐證券舉辦之興櫃前法人說明會","clause":"第9款","fact_date":"2025-11-25","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2025-11-21 17:40，「本公司受邀參加兆豐證券舉辦之興櫃前法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4732-2025-11-21-1656-1clt9j4","company_id":"4732","company":"彥臣","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"16:56:05","subject":"代子公司公告本公司自主研發新藥NBM-BMX獲得美國食品藥物管理局(FDA)授予治療葡萄膜黑色素瘤之孤兒藥認定資格(ODD)","clause":"第44款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：彥臣（4732），2025-11-21 16:56，「代子公司公告本公司自主研發新藥NBM-BMX獲得美國食品藥物管理局(FDA)授予治療葡萄膜黑色素瘤之孤兒藥認定資格(OD」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-11-21-1638-ryd0y","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-21","time":"16:38:19","subject":"公告本公司第二次買回庫藏股已執行完畢情形","clause":"第41款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-11-21 16:38，「公告本公司第二次買回庫藏股已執行完畢情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-11-21-1629-lrkgsj","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-11-21","time":"16:29:03","subject":"公告本公司受統一證券邀請舉辦公開法人說明會","clause":"第12款","fact_date":"2025-11-24","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-11-21 16:29，「公告本公司受統一證券邀請舉辦公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-11-21-1548-uuxhb5","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-11-21","time":"15:48:24","subject":"代子公司「中化裕民健康事業(股)公司」公告法人監察人改派代表人","clause":"第6款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-11-21 15:48，「代子公司「中化裕民健康事業(股)公司」公告法人監察人改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-11-21-1547-usmyvw","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-11-21","time":"15:47:53","subject":"代子公司「中國化學製藥(股)公司」公告法人監察人改派代表人","clause":"第6款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-11-21 15:47，「代子公司「中國化學製藥(股)公司」公告法人監察人改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-11-21-1341-1406jt2","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-11-21","time":"13:41:15","subject":"公告本公司受邀參加台新證券舉辦之法⼈說明會","clause":"第12款","fact_date":"2025-11-24","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-11-21 13:41，「公告本公司受邀參加台新證券舉辦之法⼈說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-11-21-0640-1v8dyfc","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-11-21","time":"06:40:12","subject":"開發中新藥OBP-301獲日本厚生勞動省初步認定為孤兒藥","clause":"第53款","fact_date":"2025-11-21","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-11-21 06:40，「開發中新藥OBP-301獲日本厚生勞動省初步認定為孤兒藥」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}